High Prevalence of c-RET Expression in Papillary Thyroid Carcinomas from the Korean Population
Background: Activation of the RET proto-oncogene, located on the long arms of chromosome 10, contributes to the development of thyroid cancers in two different ways. First, somatic rearrangements of RET with variable activation genes are frequently found in papillary thyroid carcinomas. Second, germ...
Gespeichert in:
Veröffentlicht in: | Thyroid (New York, N.Y.) N.Y.), 2005-03, Vol.15 (3), p.259-266 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background:
Activation of the
RET
proto-oncogene, located on the long arms of chromosome 10, contributes to the development of thyroid cancers in two different ways. First, somatic rearrangements of
RET
with variable activation genes are frequently found in papillary thyroid carcinomas. Second, germ-line point mutations are responsible for the development of medullary thyroid carcinomas and multiple endocrine neoplasia type 2 (MEN 2). There are several conflicting reports on the influences of
RET
expression and
RET
/
PTC
rearrangements on the clinical outcome of thyroid cancers. Therefore, the wild-type
RET
gene expression and
RET
/
PTC
-1,
RET
/
PTC
-2,
RET
/
PTC
-3 rearrangements were examined in thyroid carcinomas and other thyroid diseases.
Materials and Methods:
Thirty-six papillary thyroid carcinomas (PTCs), 8 follicular thyroid carcinomas (FTCs), 4 anaplastic thyroid carcinomas (ATC), 7 follicular adenomas (FAs), 23 hyperplasias, 6 normal thyroid tissues, and 39 normal portions from each tumor were included in this study. Reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemical analyses were used to identify the
RET
gene and
RET
/
PTC
rearrangements.
Results:
From the RT-PCR analysis, 68.9% of the PTCs, a single case of FTC, and 22.2% of the hyperplasias expressed the
RET
gene. No
RET
gene expression was observed in ATCs, FAs, or normal thyroid
tissues. One
RET
/
PTC
-1 and one
RET
/
PTC
-2 rearrangement were detected in the PTCs. No
RET
/
PTC
-3 rearrangement
was detected in any specimen. The immunohistochemical results revealed that 66.7% of PTCs,
28.6% of FAs, and 18.2% of hyperplastic thyroid tissue specimens showed high levels of
RET
protein expression. Neither the normal thyroid tissues nor the FTCs and ATC, showed high levels of
RET
protein expression. The two methods are agreed in PTC and hyperplastic nodules, but not in FA and FTC.
Conclusion:
PTCs among Koreans rarely showed
RET
/
PTC
rearrangements, but commonly showed increased
RET
gene expression. Compared to earlier reports indicating that the expression of the
RET
gene was limited to PTCs, the
RET
gene was also expressed in hyperplasias in this study. |
---|---|
ISSN: | 1050-7256 1557-9077 |
DOI: | 10.1089/thy.2005.15.259 |